Tactile Systems Technology Priced, Nasdaq: TCMD

Sells at-home compression therapy devices for vascular swelling.

Industry: Health Care

Latest Trade: $17.66 -0.52 (-2.9%)

First Day Return: +10.8%

Return from IPO: +81.8%

Industry: Health Care

We are a medical technology company that develops and provides innovative medical devices for the treatment of chronic diseases at home. We focus on advancing the standard of care in treating chronic diseases in the home setting to improve patient outcomes and quality of life and help control rising healthcare expenditures. We possess a unique, scalable platform to deliver at-home healthcare solutions throughout the United States. This evolving care delivery model is recognized by policy-makers and payers as a key for controlling rising healthcare expenditures. Our initial area of therapeutic focus is vascular disease, with a goal of advancing the standard of care in treating lymphedema and chronic venous insufficiency. Our proprietary Flexitouch System is an at-home solution for lymphedema patients. Our proprietary ACTitouch System is a home-based solution for chronic venous insufficiency patients that may be worn throughout the day. Our products deliver cost-effective, clinically proven, long-term treatment of chronic diseases. We employ a direct-to-patient and -provider model, through which we obtain patient referrals from clinicians, manage insurance claims on behalf of our patients and their clinicians, deliver our solutions to patients and train them on the proper use of our solutions in their homes. This model allows us to directly approach patients and clinicians, whereby we disintermediate the traditional durable medical equipment channel and capture both the manufacturer and distributor margins. For the year ended December 31, 2015, we generated revenues of $62.9 million and had net income of $1.4 million. Our revenues increased 32% during the year ended December 31, 2015 compared to the year ended December 31, 2014. For the three months ended March 31, 2016, we generated revenues of $13.7 million and had a net loss of $1.0 million. Our revenues increased 35% during the three months ended March 31, 2016 compared to the three months ended March 31, 2015.
more less
IPO News for Tactile Systems Technology
more
IPO Data
IPO File Date 01/25/2016
Offer Price $10.00
Price Range $10.00 - $10.00
Offer Shares (mm) 4.0
Deal Size ($mm) $40
IPO Data
IPO Date 07/27/2016
Offer Price $10.00
Price Range $10.00 - $10.00
Offer Shares (mm) 4.0
Deal Size ($mm) $40
Underwriters
more
Company Data
Headquarters Minneapolis, MN
Founded 1995
Employees 275
Website www.tactilemedical.com